10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

5 Breakout Stocks Under $10 Set to Soar

10.31.14 | 02:13 PM

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience m...

Sell These 5 Scary Stocks Before It's Too Late

10.31.14 | 10:31 AM

BALTIMORE (Stockpickr) -- It may be Halloween, but some of the scariest stuff you see today might be in your portfolio. Must Read: Warren Buffett'...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter